SCHEMBL5762216

SCHEMBL5762216

CCn1c(=O)c(-c2c(Cl)cccc2Br)cc2cnc(Nc3ccccc3)nc21

nearest known ligand 0.87

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 0.87
EGFR P00533 4/20 0.87
WEE1 P30291 9/20 0.66
SRC P12931 2/20 0.66
FGFR2 P21802 1/20 0.66
FGFR4 P22455 1/20 0.66
FGFR3 P22607 1/20 0.66
RIPK2 O43353 1/20 0.58
ACVR1 Q04771 1/20 0.58
NOD2 Q9HC29 1/20 0.58
ABL1 P00519 1/20 0.58
PDGFRB P09619 1/20 0.58
PDGFRA P16234 1/20 0.58
MAPK14 Q16539 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5762083 0.93 FGFR1 (1.00) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5764038 0.89 FGFR1 (0.68) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5763753 0.85 FGFR1 (1.00) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5761779 0.85 FGFR1 (0.83) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5763260 0.83 FGFR1 (0.80) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5762332 0.83 FGFR1 (0.81) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5762208 0.82 FGFR1 (0.75) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL19499680 0.81 FGFR1 (0.74) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL5764524 0.80 FGFR1 (0.72) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL1249524 0.80 FGFR1 (1.00) FGFR1EGFRWEE1SRCFGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP claimed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO claimed
CN-1183099-A Pyrido [2, 3-d ] pyrimidines for inhibiting protein tyrosine kinase mediated cell proliferation WARNER LAMBERT CO (US) 1998-05-27 CN claimed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 EP claimed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 WO claimed
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP disclosed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO disclosed
CN-1083452-C Pyrido (2, 3 -d) pyrimidines for inbibiting protein tyrosine kinase mediated cellular proliferation WARNER LAMBERT CO (US) 2002-04-24 CN disclosed
CN-1183099-A Pyrido [2, 3-d ] pyrimidines for inhibiting protein tyrosine kinase mediated cell proliferation WARNER LAMBERT CO (US) 1998-05-27 CN disclosed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 EP disclosed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 WO disclosed